We are live on ! Find out more
AGTC

Applied Genetic Technologies Corporation

Delisted

AGTC was delisted on the 30th of November, 2022.

54 hedge funds and large institutions have $31.4M invested in Applied Genetic Technologies Corporation in 2018 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 13 increasing their positions, 21 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

5% more capital invested

Capital invested by funds: $30M → $31.4M (+$1.38M)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

13% less funds holding

Funds holding: 6254 (-8)

38% less repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 21

54% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 13

Holders
54
Holders Change
-8
Holders Change %
-12.9%
% of All Funds
1.24%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
6
Increased
13
Reduced
21
Closed
13
Calls
$86K
Puts
Net Calls
+$86K
Net Calls Change
+$86K
Name Holding Trade Value Shares
Change
Change in
Stake
Morgan Stanley
26
Morgan Stanley
New York
$178K -$49.4K -11,745 -20%
Bank of America
27
Bank of America
North Carolina
$174K -$12.9K -3,079 -6%
Millennium Management
28
Millennium Management
New York
$132K -$328K -78,142 -69%
MCM
29
Matarin Capital Management
New York
$126K -$14.2K -3,385 -9%
FDCDDQ
30
Federation des caisses Desjardins du Quebec
Quebec, Canada
$101K
Deutsche Bank
31
Deutsche Bank
Germany
$85K -$134K -31,791 -59%
Northern Trust
32
Northern Trust
Illinois
$80K
California Public Employees Retirement System
33
California Public Employees Retirement System
California
$69K
Two Sigma Advisers
34
Two Sigma Advisers
New York
$66K -$16.8K -4,000 -19%
PP
35
PDT Partners
New York
$64K +$22.3K +5,300 +47%
Tudor Investment Corp
36
Tudor Investment Corp
Connecticut
$57K
D.E. Shaw & Co
37
D.E. Shaw & Co
New York
$55K -$7.09K -1,688 -11%
Squarepoint
38
Squarepoint
New York
$53K -$13K -3,100 -18%
Bank of New York Mellon
39
Bank of New York Mellon
New York
$51K +$9.04K +2,151 +19%
Macquarie Group
40
Macquarie Group
Australia
$39K -$5.04K -1,200 -11%
WS
41
Wedbush Securities
California
$39K +$42.8K +10,190 New
Bank of Montreal
42
Bank of Montreal
Ontario, Canada
$20K -$60.4K -14,375 -74%
FCMT
43
Founders Capital Management (Texas)
Texas
$15K
Wells Fargo
44
Wells Fargo
California
$12K -$752 -179 -5%
IP
45
Intellectus Partners
California
$12K +$4.2K +1,000 +50%
UBS Group
46
UBS Group
Switzerland
$10K -$42.1K -10,015 -79%
Royal Bank of Canada
47
Royal Bank of Canada
Ontario, Canada
$8K -$42 -10 -0.5%
ClearBridge Investments
48
ClearBridge Investments
New York
$5K
TRCT
49
Tower Research Capital (TRC)
New York
$5K +$6.53K +1,554 New
MAM
50
Meeder Asset Management
Ohio
$3K

AGTC Hedge Fund Activity: Q1 2018 in Review

54 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Applied Genetic Technologies Corporation (AGTC) for Q1 2018, worth a combined $31.4M — up 4.6% from $30M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of AGTC and 6 opened new positions — a net loss of 7 holders — while 21 trimmed existing stakes and 13 added.

The largest buyer was Point72 Asset Management, opening a new position worth an estimated $757K. The largest seller was Fidelity Investments, cutting an estimated $456K.

  • 54 institutional investors held Applied Genetic Technologies Corporation (AGTC) as of Q1 2018, down from 62 in Q4 2017.
  • Funds reported $31.4M of Applied Genetic Technologies Corporation stock for Q1 2018, up 4.6% quarter-over-quarter.
  • 6 funds opened new Applied Genetic Technologies Corporation positions in Q1 2018 and 13 closed out, a net change of -7 holders.
  • The largest Applied Genetic Technologies Corporation buyer in Q1 2018 was Point72 Asset Management, an estimated $757K added.
  • The largest Applied Genetic Technologies Corporation seller in Q1 2018 was Fidelity Investments, an estimated $456K sold.

Based on aggregated 13F filings for Q1 2018.